CEO and Founder
A pharma industry leader and entrepreneur with a focus on driving improvements in clinical trial execution, at scale, through innovative solutions. In 1999, she founded The Avoca Group, whose Avoca Quality Consortium paved the way for Diligent Pharma and the Diligent Qualification Platform.
LeRoy Jones, MS
Chief Technology Officer
20+ years software product management and healthcare information technology, including serving as Chief Executive Officer at EREflow and GSI Health.
Jennifer Sessions, MS, LLS Certified
Vice President, Client Services
25+ years in research and development experience in industry including Eli Lilly & Co, academia, and biotechnology sectors in Clinical Development, Clinical Operations, Clinical Trial Management, Lean Six Sigma, Pharmaceutical Project Management, Vendor Relationship Management and Process Optimization and Improvement
Chief Commercial Officer
23+ years of Commercialization and R&D commercial team leadership on the service side of the Pharma/BioPharma industry. Chris has held senior leadership positions at Kantar Health leading the US Client Consulting Services sales team, as well as Chief Commercial Officer of YourEncore with a transition to a leader of the Consulting organization at Advarra when acquired.
Head of Quality
Jay leads our Quality organization that implement a risk-based qualification service for clients of Diligent to support Sponsors in their vendor risk management efforts. He has been in the pharmaceutical industry for 34 years and has held various leadership roles. Jay has a wealth of experience in GMP, GLP, GCP and GCLP environments with significant real-life experience in developing numerous new drug candidates.
Greg Bell, CPA
Head of Finance and Administration
30+ years as a Senior Financial Executive for healthcare, technology and financial services companies, including 15+ years in leadership roles for SaaS-based software companies. Most recently, he served as Chief Operating Officer at EREflow.